This special episode of the Tick Boot Camp Podcast was recorded live at the 2nd Annual Alzheimer’s Pathobiome Initiative (AlzPI) and PCOM Symposium in collaboration with Pathobiome Perspectives. Hosted by Ali Moresco in partnership with Nikki Schultek (Executive Director, AlzPI), the conversation advances the Tick Boot Camp mission of exploring infection-associated chronic illness (IACI)—including Lyme disease and other tick-borne infections—within the global Alzheimer’s and neuroimmunology community.
Tick Boot Camp co-founders Matt Sabatello and Rich Johannesen partnered with Ali and Nikki to amplify voices connecting tick-borne illness, microbes, and cognitive decline. This episode features Nicole Bell—author, entrepreneur, and CEO of Galaxy Diagnostics—whose memoir What Lurks in the Woods documents her late husband Russ’s misdiagnosed tick-borne illness and their search for answers.
At the Symposium, Nicole presented “When the brain pathobiome becomes personal,” sharing her family’s journey and new findings from Russ’s donated brain: laboratory evidence of Borrelia burgdorferi, Chlamydia pneumoniae, and Babesia otocoli (a species long thought to be deer-restricted) in brain tissue—data now being prepared for publication. Researchers also noted elevated heavy metals (lead, mercury), underscoring how polymicrobial infection plus toxic exposures may converge to drive neuroinflammation and Alzheimer’s-like decline.
Nicole details how repeated “normal” neurology workups masked a complex pathobiome process. She explains why standard two-tier Lyme serology can miss true infection, how direct detection can change care, and why patients should consider Bartonella and Babesia alongside Lyme. She outlines hallmark Bartonella clues—including striæ that resemble stretch marks (often more visible after hot showers), neuropsychiatric manifestations (irritability, anxiety, OCD, tics), ocular and joint involvement—and highlights non-tick vectors (notably fleas and household cats) that expand risk beyond forest exposure.
Nicole advocates for building a diagnostic toolkit that combines serology with sensitive direct tests to clarify which pathogens are active—critical because Borrelia, Bartonella, and Babesia require different treatment paradigms. Looking forward, she envisions comprehensive screening panels for midlife cognitive changes that integrate pathogen load, host immune signatures, and toxin status, enabling earlier, targeted interventions.
“Everyone wants a simple A→B. But the toughest chronic conditions are subtle and multifactorial. Accurate data, direct detection, and a clinician who will go on the journey with you can change everything.” — Nicole Bell
Nicole’s story humanizes the science: polymicrobial infection + toxins + host factors can look “psychiatric” or “idiopathic” until modern testing reveals the underlying pathobiome. Her advocacy pushes medicine toward precision diagnostics, earlier detection, and pathogen-informed care that may prevent years of decline.
Recorded at the 2nd Annual Alzheimer’s Pathobiome Initiative (AlzPI) and Philadelphia College of Osteopathic Medicine (PCOM) Symposium on October 3, 2025, at Ohio University (Dublin, Ohio). The meeting convened global experts investigating how microbes, the microbiome, and immune responses contribute to Alzheimer’s, dementia, PANS/PANDAS, and other infection-associated chronic illnesses (IACI). This episode is part of a Tick Boot Camp series connecting chronic Lyme research with cutting-edge brain-immune science.
This special episode of the Tick Boot Camp Podcast was recorded live at the 2nd Annual Alzheimer’s Pathobiome Initiative (AlzPI) and PCOM Symposium in collaboration with Pathobiome Perspectives. Hosted by Ali Moresco in partnership with Nikki Schultek, Executive Director of AlzPI, the conversation brings the Tick Boot Camp mission of exploring infection-associated chronic illness (IACI)—including Lyme disease and other tick-borne infections—to the global Alzheimer’s and neuroimmunology research community.
Tick Boot Camp co-founders Matt Sabatello and Rich Johannesen partnered with Ali and Nikki to highlight leading scientists connecting infection, immune dysfunction, and cognitive decline. This episode features Dr. Sean Miller, a neuroscientist and co-investigator in the Logan Lab with a primary appointment at Yale School of Medicine, who is developing ways to non-invasively detect Alzheimer’s-like pathology through the eye.
Dr. Sean Miller completed pre-doctoral work at Harvard Medical School, earned his PhD from Johns Hopkins University, and completed post-doctoral training at Stanford University. His research focuses on neurodegeneration, neuroglia, and early diagnostic strategies for Alzheimer’s and related diseases.
At the AlzPI & PCOM Symposium, Dr. Miller presented evidence showing that SARS-CoV-2 (COVID-19) infection can accelerate Alzheimer’s-like pathology and that these changes can be detected non-invasively through retinal imaging. His findings suggest that amyloid-beta, a protein long associated with Alzheimer’s disease, may also serve as part of the brain’s antimicrobial defense system—trapping pathogens like a mesh or biofilm, but leading to damaging plaque buildup when overproduced.
Dr. Miller describes how the COVID-19 virus can act as an infectious trigger for neuroinflammation and amyloid buildup, how the eye provides a unique window into the brain, and why early detection is essential to preventing neuron death. He shares how his lab’s AI-enhanced retinal imaging research at Yale Eye Center is identifying amyloid and tau deposits in patients with long COVID-related brain fog—opening the possibility of routine eye exams doubling as early Alzheimer’s screening tools.
He explains potential therapeutic strategies, such as limiting amyloid production during infection flare-ups and enhancing clearance mechanisms afterward to reduce chronic plaque formation. The conversation also explores his scientific journey—from designing Alzheimer’s drugs at Harvard and Johns Hopkins to realizing the need for early disease detection during his postdoc at Stanford—and how the pandemic inspired his focus on infection-induced neurodegeneration.
“We believe neurons are exposed to pathogens in the central nervous system and respond by secreting amyloid-beta to trap them. Excessive plaque buildup from repeated or severe infections may be what drives long-term neurodegeneration.” — Dr. Sean Miller
Dr. Miller’s research connects infectious disease, ophthalmology, and neurology, providing a revolutionary new method to screen for early Alzheimer’s-like changes non-invasively through the human eye. His work suggests that infections like COVID-19 may trigger the same protective—but damaging—immune responses implicated in chronic conditions such as Alzheimer’s disease and infection-associated cognitive decline.
The interview took place at the 2nd Annual Alzheimer’s Pathobiome Initiative (AlzPI) and Philadelphia College of Osteopathic Medicine (PCOM) Symposium, held on October 3, 2025, at Ohio University in Dublin, Ohio. The event brought together more than 20 global researchers exploring how microbes, the microbiome, and the immune response contribute to Alzheimer’s, dementia, PANS/PANDAS, and infection-associated chronic illnesses (IACI).
Tick Boot Camp partnered with Ali Moresco and Nikki Schultek to share the voices of researchers advancing the field of infection-associated chronic illness. This episode is part of a multi-part Tick Boot Camp series highlighting how pathobiome and microbiome science are transforming the understanding of Lyme disease, infection, and neurodegeneration.
Learn more about the Alzheimer’s Pathobiome Initiative (AlzPI)
Listen to Tick Boot Camp Podcast episodes, including Episode 406: Pathobiome – An Interview with Nikki Schultek and Episode 101: The Young Gun – An Interview with Alex (Ali) Moresco discussed in this interview.
This special episode of the Tick Boot Camp Podcast was recorded live at the 2nd Annual Alzheimer’s Pathobiome Initiative (AlzPI) and PCOM Symposium in collaboration with Pathobiome Perspectives. Hosted by Ali Moresco in partnership with Nikki Schultek, Executive Director of AlzPI, the conversation brings the Tick Boot Camp mission of exploring infection-associated chronic illness (IACI), like Lyme disease and other tick-borne diseases, to the global Alzheimer’s and neuroimmunology research community.
Tick Boot Camp co-founders Matt Sabatello and Rich Johannesen partnered with Ali and Nikki to highlight scientists whose work connects tick-borne illness, microbes, and cognitive decline. This episode features Dr. Brian J. Balin, an internationally recognized neuroscientist whose research has redefined the role of infection in contributing to Alzheimer’s disease.
Dr. Balin directs the Center for Chronic Disorders of Aging and the Adolph and Rose Levis Foundation Laboratory for Alzheimer’s Disease Research at PCOM. With a PhD from the University of Maryland School of Medicine and postdoctoral training at the University of Pennsylvania, he has devoted nearly three decades to understanding how chronic infection and inflammation trigger neurodegeneration.
His pioneering discovery that the respiratory bacterium Chlamydia pneumoniae infects brain tissue helped establish the Pathogen Hypothesis of Alzheimer’s disease. His continuing work explores how tick-borne microbes — including Borrelia burgdorferi (Lyme disease), Bartonella, and Babesia — interact with other pathogens to drive neuroinflammation and cognitive decline.
“Infection is part of the exposome — an environmental insult that shapes our health over a lifetime. Recognizing that is key to truly understanding and preventing Alzheimer’s disease.” — Dr. Brian J. Balin
Dr. Balin’s research bridges the worlds of neurology and infectious disease, offering a framework that could revolutionize how Alzheimer’s and other neurodegenerative conditions are diagnosed and treated. By recognizing that microbes — including those transmitted by ticks — can initiate neuroinflammation and cognitive decline, his work provides hope for millions living with infection-associated chronic illness.
The interview took place at the 2nd Annual Alzheimer’s Pathobiome Initiative (AlzPI) and Philadelphia College of Osteopathic Medicine (PCOM) Symposium, October 3, 2025, Ohio University in Dublin, Ohio. The Symposium brought together more than 20 experts exploring how microbes, the microbiome, and the host immune response contribute to neurological and psychiatric diseases such as Alzheimer’s, dementia, and PANS/PANDAS.
Tick Boot Camp partnered with Ali Moresco and Nikki Schultek to document and share the voices of scientists advancing research on infection-associated chronic illness (IACI). This episode is part of a special series showcasing how pathobiome and microbiome science is changing our understanding of chronic Lyme and neurodegenerative disease.
This special episode of the Tick Boot Camp Podcast was recorded live at the 2nd Annual Alzheimer’s Pathobiome Initiative (AlzPI) and PCOM Symposium in collaboration with Pathobiome Perspectives. Hosted by Ali Moresco in partnership with Nikki Schultek, Executive Director of AlzPI, the conversation brings the Tick Boot Camp mission of exploring infection-associated chronic illness (IACI)—like Lyme disease and other tick-borne infections—to the global Alzheimer’s and neuroimmunology research community.
Tick Boot Camp co-founders Matt Sabatello and Rich Johannesen partnered with Ali and Nikki to highlight scientists whose work connects tick-borne illness, microbes, and cognitive decline. This episode features Yuri Kim, RN, Lead Clinical Research Nurse for the MAESTRO Study at the Massachusetts Institute of Technology (MIT), who is leading pioneering work to measure and understand “brain fog” in infection-associated chronic illness.
Yuri Kim is the Lead Clinical Research Nurse for the MAESTRO Study, the largest clinical study ever conducted at MIT, led by Dr. Michal “Mikki” Caspi Tal, immunologist and immunoengineer at the Massachusetts Institute of Technology. The MAESTRO Study investigates infection-associated chronic illnesses (IACI) such as chronic Lyme disease and aims to objectively measure and understand one of the most debilitating and misunderstood symptoms—brain fog.
Yuri has conducted more than 170 participant study visits and integrates patient narratives with advanced neurocognitive, immune, and molecular profiling. Her background includes experience as a trauma ER nurse and clinical research manager on neurodegenerative and rare diseases such as Alzheimer’s disease, chronic traumatic encephalopathy (CTE), and amyloidosis.
“Brain fog isn’t just a symptom—it’s a phenomenon interconnected with multiple systems. We’re trying to narrow the gap between what patients report and what we can measure.” — Yuri Kim
Yuri Kim’s work at MIT bridges patient experience and advanced science to address one of the most misunderstood symptoms in infection-associated chronic illness: brain fog. Her research within the MAESTRO Study, under the leadership of Dr. Michal “Mikki” Caspi Tal, is generating objective evidence that validates patient experiences and reveals how chronic infection and immune dysregulation can cause measurable cognitive and physiological changes.
By studying infection-associated brain fog in Lyme disease and other chronic conditions, Yuri and the MAESTRO team are helping to shape a new era of diagnostics and care for people living with long-term, infection-driven illness.
The interview took place at the 2nd Annual Alzheimer’s Pathobiome Initiative (AlzPI) and Philadelphia College of Osteopathic Medicine (PCOM) Symposium, held on October 3, 2025, at Ohio University in Dublin, Ohio. The Symposium brought together more than 20 international experts investigating how microbes, the microbiome, and the host immune response contribute to neurological and psychiatric conditions such as Alzheimer’s, dementia, and PANS/PANDAS.
Tick Boot Camp partnered with Ali Moresco and Nikki Schultek to capture and share the voices of scientists advancing research on infection-associated chronic illness (IACI). This episode is part of a special Tick Boot Camp series spotlighting how pathobiome and microbiome science are transforming the understanding of chronic Lyme, cognitive dysfunction, and neurodegeneration.
In this powerful episode of the Tick Boot Camp Podcast, international DJ and artist duo Z3LLA — Julia “Juj” Seeley and Kiana Tebyani — share how chronic illness, creativity, and friendship became the foundation of their success.
After years of unexplained symptoms, Juj was diagnosed with Lyme disease, Bartonella, Babesia, mold toxicity, POTS, SIBO, celiac disease, and later catamenial epilepsy. Despite life-altering health challenges, she and her best friend Kiana have built Z3LLA into one of the most exciting names in house music — with their single “Why Should I?” reaching #1 on the US Dance Radio Charts and performances alongside Disco Lines, Galantis, and Bijou.
Together, Juj and Kiana discuss performing through flare-ups, collapsing backstage, navigating the medical system, and the emotional toll of chasing dreams while managing invisible illness. From ER visits and red-light therapy to steroid crashes and spiritual breakthroughs, this episode is a masterclass in resilience, vulnerability, and using art as advocacy.
Z3LLA is an award-winning artist/DJ duo composed of Julia “Juj” Seeley and Kiana Tebyani, two vocalists, songwriters, and producers redefining what it means to thrive as women in electronic music. Known for their infectious energy and empowering message, Z3LLA’s breakout single “Why Should I?” hit #1 on the US Dance Radio Charts, with spins on SiriusXM BPM, Music Choice, and Evolution Radio. They’ve shared the stage with Disco Lines, Galantis, and Bijou, earned the Level Future of Dance Award from Nexus Radio, and performed at Miami Music Week and beyond. With an authentic blend of vulnerability and power, Z3LLA is not just creating music — they’re building a movement.
Follow Z3LLA: 🎧 Spotify | 📸 Instagram | 🎵 Apple Music | 🌐 YouTube
In this special Tick Boot Camp Podcast episode, Dr. Myriah Hinchey (ND) joins Matt Sabatello and Rich Johannesen from Tick Boot Camp to spotlight the 2025 LymeBytes Symposium, a physician- and patient-focused conference designed to shorten the healing journey for Lyme, mold illness, PANS/PANDAS, Long COVID, and other complex, infection-driven chronic conditions. We dig into why immersive learning accelerates progress, how an intimate format fuels direct access to top clinicians and vendors, and what attendees—both in-person and virtual—will actually experience over two packed days in Fort Lauderdale.
If travel isn’t possible, don’t wait—join virtually to access the same lectures, slides, and full-day recordings. And if you can make it to Florida, come say hi to Rich and the Tick Boot Camp crew in person.
👉 Register now: shop.lymebytes.com | Use code TBC100 for $100 off.
Recorded in person in Central Park, NYC just before Project Lab Coat at New York Fashion Week (NYFW), this Tick Boot Camp Podcast features Dr. Bill Rawls on what helps chronic Lyme patients move from overwhelm to progress. We talk immune-first strategy, why antibiotics often fall short in chronic cases, how to protect the gut, and a stepwise plan that reduces flare risk and builds confidence.
Dr. Rawls explains why stealth microbes like Borrelia, Bartonella, and Babesia grow slowly and hide in tissues, which is why a quick-fix antibiotic approach often disappoints in chronic illness. We discuss a four-phase healing framework — prehabilitation, assist the immune system, rehabilitation, and maintenance (PARM) — and how a gradual, system-calming on-ramp helps patients tolerate protocols without crashing. We also dig into gut protection, community support, and how AI can speed education and research.
Dr. Geoff Dow, CEO of 60 Degrees Pharmaceuticals and former malaria drug developer at Walter Reed, joins the Tick Boot Camp Podcast to unpack the science and strategy behind treating babesiosis.
Drawing parallels to malaria, Dow explains why tafenoquine (brand: Arakoda), FDA-approved for malaria prevention, is being studied for Babesia, how coinfections (Borrelia, Bartonella) complicate care, and why chronic illness needs a different clinical approach.
He previews an upcoming Mount Sinai trial for chronic babesiosis focused on fatigue outcomes and discusses real-world diagnostics using FDA-approved blood donor screening plus PCRs from Galaxy Diagnostics and Mayo Clinic.
The conversation also touches on prophylaxis concepts, immune dysregulation, and building a clearer path from anecdote to evidence for the tick-borne disease community.
Geoff Dow, BSc, MBA, PhD CEO & Board Member, 60 Degrees Pharmaceuticals Background: Biotechnology (Perth, Australia), PhD in malaria drug discovery, decade at Walter Reed Army Institute of Research, MBA in the U.S. Leads clinical programs exploring tafenoquine for babesiosis.
In this special Tick Boot Camp Podcast episode recorded live at Project Lab Coat during New York Fashion Week (NYFW), we sit down with Colonel Nicole Malachowski, USAF (Ret.).
Col. Malachowski, the first female pilot of the USAF Thunderbirds and a Lyme patient advocate, walked the runway with us at Project Lab Coat and served as the sole patient representative on the National Academies of Sciences, Engineering, and Medicine committee that authored the landmark report on Lyme infection-associated chronic illness (Lyme IACI).
She shares her perspective on why this recognition is a historic milestone for the Lyme community.
Col. Malachowski is a retired U.S. Air Force fighter pilot, the first woman selected to fly with the USAF Thunderbirds, and a National Women’s Hall of Fame inductee. After contracting a tick-borne illness and being medically retired, she became a nationally recognized speaker and advocate for Lyme patients. She served as the sole patient voice on the National Academies committee that authored the landmark report on Lyme IACI, commissioned with support from the Steven & Alexandra Cohen Foundation.
Project Lab Coat was a groundbreaking event held on September 13, 2025, during New York Fashion Week (NYFW). The show brought together prominent celebrities, researchers, doctors, and advocates who were invited to walk the runway to spotlight Lyme disease and raise funds for Lyme disease research.
For the first time, the global visibility of NYFW was used to highlight one of the fastest-growing infectious diseases in the world. Tick Boot Camp co-founders Matt Sabatello and Rich Johannesen, together with Dr. Tal, walked the runway at Project Lab Coat, joining leaders from medicine, science, entertainment, and advocacy. Project Lab Coat demonstrated the power of mainstream platforms to bring awareness, credibility, and resources to the fight against Lyme disease.
In this special Tick Boot Camp Podcast episode recorded live at Project Lab Coat during New York Fashion Week (NYFW), we sit down with Dr. Michal “Mikki” Caspi Tal, Principal Scientist in the Department of Biological Engineering at MIT and Associate Scientific Director of the MIT Center for Gynepathology Research.
Dr. Tal is an immunologist and immunoengineer whose groundbreaking research focuses on the connections between infections and chronic diseases, including Lyme disease and long COVID. At her Tal Research Group lab, she studies why some people recover quickly after infection while others develop chronic illness, with a focus on the immune system’s different responses in men and women.
Project Lab Coat was a groundbreaking event held on September 13, 2025, during New York Fashion Week (NYFW). The show brought together prominent celebrities, researchers, doctors, and advocates who were invited to walk the runway to spotlight Lyme disease and raise funds for Lyme disease research.
For the first time, the global visibility of NYFW was used to highlight one of the fastest-growing infectious diseases in the world. Tick Boot Camp co-founders Matt Sabatello and Rich Johannesen, together with Dr. Tal, walked the runway at Project Lab Coat, joining leaders from medicine, science, entertainment, and advocacy. Project Lab Coat demonstrated the power of mainstream platforms to bring awareness, credibility, and resources to the fight against Lyme disease.
For too long, chronic Lyme patients have been told their symptoms are “all in their head.” Dr. Tal’s work at MIT proves otherwise by measuring the real biological differences in immune system responses. This research not only validates patients’ experiences but also charts a course toward better diagnostics, clinical trials, and personalized treatments.